Induction of Cdc25B regulates cell cycle resumption after genotoxic stress

被引:35
作者
Bansal, Pallavi [1 ]
Lazo, John S. [1 ]
机构
[1] Univ Pittsburgh, Dept Pharmacol, Drug Discovery Inst, Pittsburgh, PA 15260 USA
关键词
D O I
10.1158/0008-5472.CAN-06-3685
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cdc25 phosphatases propel cell cycle progression by activating cyclin-dependent kinases (Cdk). DNA damage is generally thought to inhibit Cdc25 functionality by inducing proteasomal degradation of Cdc25A and phosphorylation-mediated sequestration of Cdc25B and Cdc25C to the cytoplasm. More recently, a critical role for Cdc25B in the resumption of cell cycle progression through mitosis after DNA damage has been identified. In this study, the fate of Cdc25B after mechanistically distinct DNA-damaging agents (etoposide, cisplatin, bleomycin, ionizing irradiation, or UV irradiation) was examined, and surprisingly a rapid increase in cellular Cdc25B levels was observed after DNA damage. Using UV irradiation as the prototypic damaging agent, we found that the increase in Cdc25B levels was checkpoint dependent and was controlled by a p53-independent mechanism. Cdc25B levels controlled the number of cells progressing into mitosis after UV, but they did not affect G(2)-M checkpoint engagement immediately after DNA damage. Increased Cdc25B reduced the time required for cell cycle resumption. These data support a model in which Cdc25B accumulation is an important anticipatory event for cell cycle resumption after DNA damage.
引用
收藏
页码:3356 / 3363
页数:8
相关论文
共 51 条
  • [1] Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?
    Baldin, V
    Cans, C
    SupertiFurga, G
    Ducommun, B
    [J]. ONCOGENE, 1997, 14 (20) : 2485 - 2495
  • [2] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [3] Broggini M, 2000, ANTICANCER RES, V20, P4835
  • [4] Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression
    Bugler, Beatrix
    Quaranta, Muriel
    Aressy, Bernadette
    Brezak, Marie-Christine
    Prevost, Gregoire
    Ducommun, Bernard
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (06) : 1446 - 1451
  • [5] Dual phosphorylation controls Cdc25 phosphatases and mitotic entry
    Bulavin, DV
    Higashimoto, Y
    Demidenko, ZN
    Meek, S
    Graves, P
    Phillips, C
    Zhao, H
    Moody, SA
    Appella, E
    Piwnica-Worms, H
    Fornace, AJ
    [J]. NATURE CELL BIOLOGY, 2003, 5 (06) : 545 - 551
  • [6] Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase
    Bulavin, DV
    Higashimoto, Y
    Popoff, IJ
    Gaarde, WA
    Basrur, V
    Potapova, O
    Appella, E
    Fornace, AJ
    [J]. NATURE, 2001, 411 (6833) : 102 - 107
  • [7] Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis
    Busino, L
    Chiesa, M
    Draetta, GF
    Donzelli, M
    [J]. ONCOGENE, 2004, 23 (11) : 2050 - 2056
  • [8] Proteasome-dependent degradation of human CDC25B phosphatase
    Cans, C
    Ducommun, B
    Baldin, V
    [J]. MOLECULAR BIOLOGY REPORTS, 1999, 26 (1-2) : 53 - 57
  • [9] Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway
    Chen, F
    Zhang, Z
    Bower, J
    Lu, YJ
    Leonard, SS
    Ding, M
    Castranova, V
    Piwnica-Worms, H
    Shi, XL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) : 1990 - 1995
  • [10] Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase
    Chen, MS
    Hurov, J
    White, LS
    Woodford-Thomas, T
    Piwnica-WormS, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (12) : 3853 - 3861